Debt to EBITDA ratio Analysis of Corvus Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of CRVS
Dec-23-0.0458Very Poor Debt to EBITDA | Dec-22-0.0305Very Poor Debt to EBITDA | Growth-50.38% |
Debt to EBITDA Analysis of Corvus Pharmaceuticals Inc
| Debt to EBITDA Ratio of CRVS drastically fell by -50.38 % this year. |
| Debt to EBITDA Ratio with value of -0.0191 was highest in Year Dec-19 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.201 was lowest in Year Dec-20 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.0458 is Greater than Average Debt to EBITDA of -0.064 in last five years. |
Other Debt to EBITDA Related Info of CRVS that may interest you.
Corvus Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| CRVS | 2.04 | 2.12 | 3.77 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to EBITDA of Corvus Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.0458 | -0.0305 | -0.0242 | -0.201 | -0.0191 | 0 | 0 |
| Change | -50.38 % | -26.05 % | 87.97 % | -951.49 % |
FY Chart of Debt to EBITDA of Corvus Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)